The patients who were transfusion dependent and switched from Soliris were forced to switch back to the Alexion drug. Source: BioSpace

Sanofi terminated an experimental Clostridium difficile vaccine after an Independent Data Monitoring Committee concluded the Phase III trial was unlikely to hit its endpoints. Source: BioSpace

Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace

Sanofi said the analysis showed more cases of severe disease could occur following vaccination in patients who had not been previously infected by the dengue virus. Source: BioSpace

Following FDA priority review, Repatha is the only PCSK9 inhibitor approved to reduce risk of heart attack, stroke and coronary revascularization. Source: BioSpace

A look at two life science companies that are expected to grow more than 67 percent over the next five years. Source: BioSpace

Today, Janssen Biotech announced it had exercised its option to enter into a collaboration deal with Idorsia to jointly develop and market aprocitentan and any derivative compounds. Source: BioSpace

The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace

Gilead will partner with three coordinating centers to lead the corporate giving program of the initiative. Source: BioSpace

Shares of Ultragenyx are sharply climbing this morning after the company announced positive results from its Phase III study of burosumab in adults with XLH. Source: BioSpace